Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

TCT 2022 | BYPASS CTCA

Studies have shown that the use of computed tomography cardiac angiography (CTCA) prior invasive coronary angiography (ICA) in patients with prior cardiac artery bypass graft (CABG) might reduce procedural time and post procedure kidney injury. 1 out of 5 patients with ischemic cardiomyopathy and prior CABG need to be assessed with ICA within 3 years after procedure. 

TCT 2022

The aim of this single center, prospective, randomized study called BYPASS CTCA was to assess whether the use of CTCA can reduce procedural time, improve patient satisfaction and prevent procedural complication in CABG patients assessed by ICA. 

It included 688 patients. 344 were randomized to CTCA + ICA and 344 to ICA alone. Mean age was 70 and most patients were men.  

Primary end point was procedure duration, incidence of contrast induced nephropathy and patient satisfaction assessed by a score. Secondary end point included procedural complications and major cardiovascular events (MACE) at 12 months. 

As regards primary end point, the use of CTCA saw an improvement associated to the invasive study. Procedure duration was 17.38 minutes with CTCA vs 39.5 without it, with 66% relative risk reduction (p<0.001), and patient satisfaction improved 40% with the use of CTCA (p<0.001), while contrast induced nephropathy incidence was 27.9% without CTCA vs 3.4% with CTCA (92% relative risk reduction, p<0.0001). 

Read also: TCT 2022 | PROTECTED TAVR.

As regards secondary end point, the use of CTCA + ICA resulted in lower procedural complications (2.33% vs 10.82%, p<0.001) and MACE rates at 12 months (16.28 vs 29.36%, p< 0.002).

Conclusion

In patients with prior CABG undergoing invasive coronary angiogram, the use of CTCA should be considered, seeing as is shortens procedural time, improves patient satisfaction and reduces contrast induced nephropathy. In addition, the use of CTCA reduces complications rate and MACE rate at 12 months. 

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: A Randomized Controlled Trial Assessing The Value Of Computed Tomography Cardiac Angiography (CTCA) In Improving Patient Satisfaction And Reducing Contrast Load, Procedural Duration And Complications In Patients Who Had Previous Bypass Operation (CABG). Results from the BYPASS CTCA Trial.

Reference: Daniel A. Jones et al.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...